01
Generalized Myasthenia Gravis (gMG)
We Support Research Advancing Immunology Forward
Our Grants program funds independent medical education initiatives that raise the standard of care for people living with diseases that have been underserved. Progress in this field rarely comes from one place, so we invest in the people and institutions doing the work alongside us.
Independent Medical Education
In keeping with our core focus: “We live to innovate—and do so at every step,” argenx is committed to supporting innovative, high-quality, objective, scientifically accurate, and fair-balanced independent medical education (IME) initiatives through unrestricted educational grants. We support continuing professional development (CPD) of healthcare professionals (HCPs) to develop knowledge and skills that will drive improvements in patient care.
IME is education for HCPs provided by an independent educational provider to close knowledge, competence, performance, and quality gaps among HCPs, helping to improve patient health and outcomes.
Eligible grant applicants may include, but are not limited to, academic institutions, medical universities, community health centers, hospitals, medical societies, professional associations, quality organizations, and medical education companies. We accept grant applications in response to our publicly posted request for proposals (RFPs) as well as unsolicited grant applications based on our areas of interest. We support both accredited/certified continuing medical education (CME) and unaccredited/non-certified IME initiatives.
Current areas of interest include:
02
Ocular Myasthenia Gravis (oMG)
03
Idiopathic Inflammatory Myopathies (IIM)
04
MuSK antibody positive, LRP4 antibody positive, and triple seronegative Myasthenia Gravis
05
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
06
Multifocal Motor Neuropathy (MMN)
Grant Applications
Grant applications undergo a formal review process, where proposals are evaluated based on educational need, design, scientific rigor, and compliance with both industry and argenx regulations.
All submitted grant proposals are reviewed regardless of whether they were submitted in response to an RFP. However, argenx clinical interests will be prioritized. The approval of a grant application is competitive in nature and the final decision is made by the argenx grant review committee.
Grant Requirements & Guidelines
argenx will have no influence over the educational content, design, format, learning objectives, faculty, or assessment of educational effectiveness of IME grants. Grants cannot include any tangible benefits to argenx beyond an acknowledgement (e.g., “Supported by an independent educational grant from argenx.”).
All IME grants must comply with and adhere to the Standards for Integrity and Independence of the Accreditation Council for Continuing Medical Education (ACCME), the principles established by the Office of the Inspector General (OIG) Compliance Guidance for Pharmaceutical Manufacturers, and Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Medical Professionals.
All requests for grant funding must be submitted at least 60 days in advance of the activity start date.
Any change of scope must be submitted at least 30 days in advance of the activity start date and must be approved by argenx prior to the activity start date.
Preference will be given to activities that achieve Moore‘s level 3 outcomes or higher.
- Grant Reconciliation: Grants recipients should acknowledge the funds were utilized for their intended purpose and if there are remaining funds please refund argenx in the original payment method.
- IME Outcomes: For live/ongoing grants please share outcomes, highlighting your insights and findings. This template is merely an example of elements to include. Please utilize the most impactful format that you deem appropriate.
Live Activities:
- Immediate Post-Live Outcomes Report: Please submit within 5 business days after the completion of the live (in-person or virtual) activity.
Live/Enduring Activities:
- Interim Outcomes Report: Please submit no later than 90–120 days after the start of the activity.
- Final Outcomes Report: Please submit no later than 30–60 days after the completion of the activity.
Current Open Requests for Proposals
There are currently no open requests for proposals.
Apply for a Grant
All submitted grant proposals are reviewed regardless of whether they were submitted in response to a current RFP; however, RFP responsive proposals will be prioritized. Should your organization be interested in submitting a proposal, please click on the hyperlink below.
To access the portal to submit a grant application, please register and log in to the argenx Grants Portal.
Explore More
At argenx, every piece of the innovation story connects. See where it leads next.
Ethics & Responsibility
Explore how we‘re doing things the right way and staying true to our core values.
Our Leaders
Meet the team driving our co-creation model forward.
About Us
Discover why we‘re more than a unique name.
